XML 64 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Stock Option Valuation Assumptions
The fair value of stock option awards in 2020 and 2019 was determined on the grant date using the Black-Scholes valuation model based on the following assumptions:
20202019
Expected term (years) (1)
5.96 – 6.02
5.27 – 6.02
Current stock value
$1.67 – $5.64
$1.28 – $1.67
Expected volatility (2)
49.3% – 51.9%
44.6% – 49.3%
Risk-free interest rate (3)
0.4% – 1.8%
1.6% – 1.9%
Dividend yield (4)
%%
(1)The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern.
(2)Volatility, or the standard deviation of annualized returns, was calculated based on comparable companies’ reported volatilities.
(3)Risk free rate was obtained from US treasury notes for the expected terms noted as of the valuation date.
(4)The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future.
Schedule of Stock Option Activity
A summary of the Company’s stock option activity for the years ended December 31, 2020 and 2019 was as follows:
Number of
Common
Stock Options
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic Value
(In Thousands)
Outstanding as of December 31, 2018— $— 
Granted5,002,390 1.67 
Forfeited(14,313)1.67 
Outstanding as of December 31, 20194,988,077 1.67 
Granted12,904,692 1.67 
Forfeited(1,704,698)1.67 
Outstanding as of December 31, 202016,188,071 $1.67 9.35$523,401 
Vested and exercisable as of December 31, 20202,524,151 $1.67 8.87$81,612 
Vested and expected to vest as of December 31, 202016,188,071 $1.67 9.35$523,401 
Schedule of Restricted Stock Activity
Employee restricted stock activity for the years ended December 31, 2020 and 2019 was as follows:
SharesWeighted Average
Grant Date Fair Value
per Share
Outstanding as of December 31, 201822,849,169 $0.22 
Granted2,055,545 1.29 
Forfeited(1,324,245)0.53 
Vested(17,333,998)0.14 
Outstanding as of December 31, 20196,246,471 0.80 
Granted— — 
Forfeited(1,667,349)0.86 
Vested(2,770,458)0.74 
Outstanding as of December 31, 20201,808,664 1.15 
Non-employee restricted stock activity for the years ended December 31, 2020 and 2019 was as follows:
SharesWeighted Average
Grant Date Fair
Value per Share
Outstanding as of December 31, 2018234,697 $0.11 
Granted— — 
Forfeited— — 
Vested(207,449)1.29 
Outstanding as of December 31, 201927,248 1.29 
Granted— — 
Forfeited(3,123)— 
Vested(16,898)1.29 
Outstanding as of December 31, 20207,227 1.29 
Schedule of Stock-based Compensation Expense by Function
Stock-based compensation expense by function was as follows (in thousands):
Year Ended December 31,
20202019
Cost of sales$309 $92 
Research and development2,098 914 
Sales and marketing414 163 
General and administrative5,890 1,533 
Total$8,711 $2,702